InvestorsObserver
×
News Home

Will FSD Pharma Inc (HUGE) Stay at the Bottom of the Healthcare Sector?

Wednesday, March 06, 2024 12:00 PM | InvestorsObserver Analysts

Mentioned in this article

Will FSD Pharma Inc (HUGE) Stay at the Bottom of the Healthcare Sector?

The 4 rating InvestorsObserver gives to FSD Pharma Inc (HUGE) stock puts it near the bottom of the Healthcare sector. In addition to scoring higher than 5 percent of stocks in the Healthcare sector, HUGE’s 4 overall rating means the stock scores better than 4 of all stocks.

Overall Score - 4
HUGE has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on HUGE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 4 would rank higher than 4 percent of all stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With FSD Pharma Inc Stock Today?

FSD Pharma Inc (HUGE) stock is trading at $0.80 as of 11:58 AM on Wednesday, Mar 6, a drop of -$0.03, or -3.08% from the previous closing price of $0.82. The stock has traded between $0.77 and $0.82 so far today. Volume today is low. So far 81,462 shares have traded compared to average volume of 133,709 shares. Click Here to get the full Stock Report for FSD Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App